ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Washington, DC, USA:

Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers (GD-T2D)

Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers...

Active, not recruiting
Type 2 Diabetes
Drug: Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
Drug: China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

Phase 2, Phase 3

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

Rockville, Maryland, United States

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Baltimore, Maryland, United States and 44 other locations

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Hyattsville, Maryland, United States and 22 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Baltimore, Maryland, United States and 24 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Takoma Park, Maryland, United States and 81 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Baltimore, Maryland, United States and 59 other locations

(SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every ...

Enrolling
Type 1 Diabetes
Behavioral: SMA visits
Children's National
Children's National

Washington, District of Columbia, United States

with type 2 diabetes (T2D)....

Enrolling
Type 2 Diabetes
Other: Facilitated referral to a cardiometabolic team-based center
Other: Decision support
American College of Cardiology

Washington, District of Columbia, United States

Locations recently updated

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Baltimore, Maryland, United States of America and 19 other locations

The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes....

Enrolling
Insulin Treated Type 2 Diabetes Mellitus
Type 2 Diabetes
Device: twiist insulin delivery system
Deka Research and Development

Baltimore, Maryland, United States and 30 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems